Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Lymphoma, T-Cell, Cutaneous 5Lymphoma 5Leukemia, Lymphocytic, Chronic, B-Cell 5Lymphoma, Large B-Cell, Diffuse 4Leukemia, Myeloid, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Mycosis Fungoides 3Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Leukemia 3Congenital Abnormalities 3Thyroid Neoplasms 2Small Cell Lung Carcinoma 2Sezary Syndrome 2Sarcoma 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Myelodysplastic Syndromes 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Lung Neoplasms 2Leukemia, Promyelocytic, Acute 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Colorectal Neoplasms 2Burkitt Lymphoma 2Breast Neoplasms 2Astrocytoma 2Waldenstrom Macroglobulinemia 1

Interventions

Trastuzumab 2tipifarnib 1romidepsin 1pazopanib 1cixutumumab 1Streptozocin 1Sorafenib 1Salts 1Oxaliplatin 1Octreotide 1Leucovorin 1Interleukin-12 Subunit p35 1Interleukin-12 1Gefitinib 1Floxuridine 1Everolimus 1Cisplatin 1Capecitabine 1Bortezomib 1Acetates 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Insulinoma × romidepsin × Clear all
NCT00084461 2013-06-04

Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors

National Cancer Institute (NCI)

Phase 2 Terminated
25 enrolled
Endocrine

Glucagonoma, Insulinoma, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡